雾化法联合痰热清注射液治疗冠心病并发肺部感染的疗效分析

Effect observation of spray inhalation combined with Tanreqing injection in treatment of patients with coronary heart disease combined effect of pulmonary infection

目的观察分析雾化法联合痰热清注射液治冠心病并发肺部感染的临床疗效。方法选取2010年2月至2012年12月本院收治的100例冠心病并发肺部感染患者,随机分成治疗组和对照组各50例。治疗组在冠心病常规治疗上雾化法联合痰热清注射液治疗,对照组在常规治疗基础上给予雾化法治疗,比较两组患者治疗前后肺部体征,判断治疗有效率,观察患者心率变化以及心绞痛发生情况。结果治疗组患者显效35例,有效12例,无效3例,总有效率为94%,优于对照组(总有效率为78.0%),组间总有效率比较差异具有统计学意义(χ2=10.12,P<0.05)。结论雾化法联合痰热清注射液治冠心病并发肺部感染可有效地提高患者的治愈率,减少患者心绞痛次数,值得临床上推广应用。

Objective Observe and analyze the clinical effects of spray inhalation combined with Tanreqing injection in treatment of patients with coronary heart disease combined effect of pulmonary infection. Methods Total of 100 patients with coronary heart disease combined effect of pulmonary infection were randomly divided into two groups （50 cases each group）, treated group were given spray inhalation combined with Tanreqing injection based with general treatment, control group for spray inhalation, and the clinical effects after treatment were compared. Results The total effective rate of treatment group was 94%, which was higher than that in control group （78.0%）, with signiifcant difference （χ^2=10.12, P〈0.05）. Conclusions The atomization method combined Tanreqing concurrent for the treatment of coronary heart disease in patients with lung infection could effectively improve the cure rate and reduce the number of patients with angina which should be widely applied in clinical.